{"id":132108,"date":"2026-06-16T22:55:17","date_gmt":"2026-06-17T02:55:17","guid":{"rendered":"https:\/\/www.abtriva.com\/?post_type=blog&p=132108"},"modified":"2026-06-16T22:58:18","modified_gmt":"2026-06-17T02:58:18","slug":"immunohistochemistry-ihc-antibody-selection-and-optimization-guide","status":"publish","type":"blog","link":"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/","title":{"rendered":"Immunohistochemistry (IHC) Antibody Selection and Optimization Guide"},"content":{"rendered":"\n

Immunohistochemistry is one of the most visually powerful techniques in research and pathology, but it is also one of the most sensitive to antibody choice.<\/p>\n

The wrong antibody produces high background, non-specific staining, or no signal at all. The right one gives you clean, interpretable results that hold up under scrutiny.<\/p>\n

This guide covers everything you need to know about IHC antibody selection and optimization, from choosing the right primary antibody to titrating concentrations and setting up proper controls.<\/p>\n

What Makes IHC Antibody Selection Different?<\/strong><\/h2>\n

In IHC, your antibody must work in a fixed tissue environment, not in a simple buffer solution.<\/p>\n

Formalin fixation (FFPE) crosslinks proteins and can alter or mask epitopes. This means an antibody that works perfectly in Western blot may fail completely in IHC.<\/p>\n

That is why IHC-specific validation matters. Always confirm the antibody has been tested and validated specifically for immunohistochemistry before purchasing.<\/p>\n

The Complete IHC Antibody Optimization Workflow<\/strong><\/h2>\n

The workflow below provides a high-level overview of the key steps involved in successful IHC optimization.<\/p>\n \"image1.png\"\n

Figure 1: IHC Antibody Selection & Optimization Workflow<\/p>\n

Let's begin with the first step: defining your target and confirming antibody specificity.<\/p>\n

Step 1: Define Your Target and Confirm Antibody Specificity<\/strong><\/h2>\n

Start with a clear research question. What protein are you detecting? Where in the tissue do you expect to find it?<\/p>\n

Check the antibody datasheet carefully. Confirm it recognizes the correct protein, the correct species, and the correct isoform or modification relevant to your study.<\/p>\n

Look for cross-reactivity data. An antibody that also binds related proteins can produce misleading staining, especially in complex tissue environments.<\/p>\n

Key specificity checks:<\/strong><\/h3>\n
    \n
  • Confirm the antibody targets your exact protein, not just a family member<\/li>\n
  • Check species reactivity, human, mouse, rat, and other species often require different clones<\/li>\n
  • Review cross-reactivity data in the datasheet<\/li>\n
  • Look for published IHC citations, real-world use in peer-reviewed studies confirms performance<\/li>\n
  • If your protein has multiple isoforms, confirm the antibody targets the one you are studying<\/li>\n <\/ul>\n

    Step 2: Choose Between Monoclonal and Polyclonal Antibodies for IHC<\/strong><\/h2>\n

    Both monoclonal and polyclonal antibodies are used in IHC, but they have different strengths in this application.<\/p>\n

    Monoclonal Antibodies in IHC<\/strong><\/h3>\n

    Monoclonals target a single epitope. They offer high specificity and low background, ideal when clean, precise staining is the priority.<\/p>\n

    The limitation: fixation can alter the target epitope. If the monoclonal's specific epitope is masked or destroyed by formalin, you get no signal.<\/p>\n

    This is why antigen retrieval is often critical with monoclonal antibodies in FFPE tissue.<\/p>\n

    Polyclonal Antibodies in IHC<\/strong><\/h3>\n

    Polyclonals recognize multiple epitopes on the same protein. This makes them more forgiving when fixation alters some epitopes, other binding sites remain accessible.<\/p>\n

    The trade-off: polyclonals carry a higher risk of non-specific background staining, especially in tissues with high endogenous immunoglobulin content.<\/p>\n

    For most IHC applications, polyclonals are a reliable first choice \u2014 but always use an immunogen affinity-purified polyclonal, not crude whole antiserum.<\/p>\n

    Monoclonal vs. Polyclonal Antibodies in IHC<\/strong><\/h3>\n

    Monoclonal and polyclonal antibodies each offer distinct advantages in IHC. The comparison below highlights their key differences.<\/p>\n \"image2.png\"\n

    Figure 2: Monoclonal vs. Polyclonal Antibodies in IHC<\/p>\n

    Understanding these differences helps you choose the most suitable antibody for your application. Next, let's look at IHC detection methods.<\/p>\n

    Step 3: Choose the Right IHC Detection System<\/strong><\/h2>\n

    IHC detection can be direct or indirect. Each approach has trade-offs.<\/p>\n

    Direct Detection<\/strong><\/h3>\n

    The primary antibody is directly conjugated to a label (enzyme or fluorophore).<\/p>\n

    Simpler protocol, fewer steps, lower background. However, signal amplification is limited, making it less suitable for low-abundance targets.<\/p>\n

    Indirect Detection<\/strong><\/h3>\n

    An unlabeled primary antibody is followed by a labeled secondary antibody.<\/p>\n

    This is the most widely used IHC detection approach. The secondary antibody amplifies the signal and allows flexibility, you can use the same primary antibody with different secondary conjugates for chromogenic or fluorescent detection.<\/p>\n

    Chromogenic vs. Fluorescent Detection<\/strong><\/h3>\n

    Chromogenic detection (DAB for HRP, Fast Red for AP) produces a permanent color deposit visible under a standard light microscope.<\/p>\n

    Fluorescent detection (immunofluorescence) allows multiplexing, detecting multiple targets simultaneously using different fluorescent secondary antibodies.<\/p>\n

    For routine diagnostic or publication pathology, chromogenic detection is standard. For co-localization studies or spatial profiling, fluorescent detection is preferred.<\/p>\n

    Choosing the right secondary antibody for IHC:<\/strong><\/h3>\n
      \n
    • Match the secondary to the host species of your primary \u2014 anti-rabbit for rabbit primary, anti-mouse for mouse primary<\/li>\n
    • Use cross-adsorbed secondaries to minimize non-specific binding in tissue<\/li>\n
    • Use F(ab')2 fragment secondaries in tissues rich in Fc receptors, spleen, lymph node, macrophage-rich areas<\/li>\n
    • For chromogenic IHC, use HRP-conjugated secondaries with DAB or AP-conjugated with Fast Red<\/li>\n
    • For multiplexing, use fluorescent secondaries with non-overlapping emission spectra<\/li>\n <\/ul>\n

      Step 4: Antigen Retrieval \u2014 A Critical Optimization Step<\/strong><\/h2>\n

      Formalin fixation crosslinks proteins, which can block the antibody from accessing its target epitope.<\/p>\n

      Antigen retrieval reverses this crosslinking and unmasks the epitope, significantly improving staining intensity and specificity.<\/p>\n

      There are two main retrieval methods:<\/p>\n

      Heat-Induced Epitope Retrieval (HIER)<\/strong><\/h3>\n

      Sections are heated in a retrieval buffer, typically citrate buffer (pH 6.0) or EDTA buffer (pH 9.0).<\/p>\n

      HIER is the most commonly used method and works well for the majority of IHC antibodies.<\/p>\n

      pH matters: acidic citrate buffer (pH 6.0) suits many antibodies; basic EDTA buffer (pH 9.0) often works better for nuclear markers and some membrane proteins.<\/p>\n

      Proteolytic-Induced Epitope Retrieval (PIER)<\/strong><\/h3>\n

      Enzymes such as proteinase K or trypsin are used to digest crosslinks and expose the epitope.<\/p>\n

      PIER is used when heat retrieval causes tissue damage or when the antibody requires enzymatic pre-treatment, more common in collagen and extracellular matrix staining.<\/p>\n

      If one retrieval method fails, always try the other before concluding the antibody does not work.<\/p>\n

      Step 5: How to Dilute Antibodies for IHC<\/strong><\/h2>\n

      Antibody dilution is one of the most important optimization variables in IHC.<\/p>\n

      Too concentrated: high non-specific background, tissue edge artifacts, and false-positive staining.<\/p>\n

      Too dilute: weak or absent signal, even if the antibody is working correctly.<\/p>\n

      How to optimize antibody dilution for IHC:<\/strong><\/h3>\n
        \n
      • Start with the manufacturer's recommended dilution range as a guide<\/li>\n
      • For mouse monoclonal antibodies, a starting concentration of 1\u20135 \u00b5g\/mL is typical<\/li>\n
      • For rabbit polyclonal antibodies, 0.5\u20132 \u00b5g\/mL is often a good starting point<\/li>\n
      • Run a serial dilution titration, test at least 3 concentrations (e.g., 1:100, 1:500, 1:1000)<\/li>\n
      • Evaluate each dilution on both positive and negative control tissue<\/li>\n
      • Select the dilution that gives the clearest specific signal with the lowest background<\/li>\n <\/ul>\n

        Primary antibody incubation time also matters. Overnight incubation at 4\u00b0C is common and often gives better results than 1-hour room temperature incubation, especially for low-abundance targets.<\/p>\n

        Step 6: IHC Controls \u2014 Why They Are Non-Negotiable<\/strong><\/h2>\n

        Controls confirm that your staining result is real, not an artifact.<\/p>\n

        Running IHC without proper controls is a common mistake that leads to misinterpretation and rejected manuscripts.<\/p>\n

        Positive Control<\/strong><\/h3>\n

        A tissue known to express your target protein.<\/p>\n

        If the positive control stains correctly, your antibody and protocol are working. If it does not stain, the problem is in your protocol, not your experimental tissue.<\/p>\n

        Negative Control<\/strong><\/h3>\n

        A tissue known not to express your target protein.<\/p>\n

        Staining in the negative control means non-specific binding, a problem with your antibody concentration, blocking, or secondary antibody.<\/p>\n

        Isotype Control<\/strong><\/h3>\n

        Replace the primary antibody with a non-specific antibody of the same isotype and concentration.<\/p>\n

        Any staining here is non-specific background from the secondary antibody or endogenous tissue proteins, not from your primary.<\/p>\n

        No Primary Control<\/strong><\/h3>\n

        Run the full protocol but omit the primary antibody entirely.<\/p>\n

        Any staining is due to the secondary antibody alone \u2014 non-specific secondary binding or endogenous enzyme activity.<\/p>\n

        Step 7: Antibody Validation for IHC<\/strong><\/h2>\n

        Validation confirms the antibody is detecting what you claim it is detecting.<\/p>\n

        This is increasingly required by journals and funding bodies \u2014 and it is simply good science.<\/p>\n

        Methods for IHC antibody validation:<\/strong><\/h3>\n
          \n
        • Genetic knockdown or knockout, compare staining in wild-type vs. target-deleted tissue; specific signal should disappear<\/li>\n
        • Peptide blocking, pre-incubate the antibody with excess immunizing peptide; specific signal should be blocked<\/li>\n
        • Independent antibody confirmation, stain with a second antibody targeting a different epitope on the same protein; results should be consistent<\/li>\n
        • Orthogonal validation, compare IHC staining pattern with gene expression data (RNA-seq, qPCR) for the same tissue<\/li>\n
        • Recombinant protein overexpression, cells transfected to overexpress the target should show stronger staining than controls<\/li>\n <\/ul>\n

          Validated antibodies from AbTrivia include application-specific validation data, so you can confirm IHC performance before your first experiment.<\/p>\n

          Multiplex IHC: Using Two Antibodies on the Same Section<\/strong><\/h2>\n

          Multiplexing allows simultaneous detection of two or more targets on a single tissue section.<\/p>\n

          When using two primary antibodies from different host species, standard indirect detection works well, each species-specific secondary binds only its matched primary.<\/p>\n

          When using two primary antibodies from the same host species, the protocol becomes more complex. You typically need to stain, inactivate the first primary-secondary complex, and then repeat the process with the second primary.<\/p>\n

          Cross-adsorbed secondary antibodies are essential for multiplex IHC, without them, secondaries bind to the wrong primary and produce false co-localization.<\/p>\n

          Common IHC Antibody Mistakes to Avoid<\/strong><\/h2>\n
            \n
          • Using an antibody validated for Western blot but not tested for IHC<\/li>\n
          • Skipping antigen retrieval, or using the wrong retrieval buffer for your antibody<\/li>\n
          • Not titrating the primary antibody concentration in your specific tissue type<\/li>\n
          • Using whole antiserum polyclonal antibodies instead of affinity-purified versions<\/li>\n
          • Omitting proper controls, positive, negative, isotype, and no-primary<\/li>\n
          • Using a mouse primary antibody on mouse tissue without blocking endogenous mouse IgG first<\/li>\n
          • Not considering Fc receptor-rich tissues, always use F(ab')2 secondaries in spleen, lymph node, and macrophage-dense areas<\/li>\n
          • Reusing diluted primary antibody beyond its stability window \u2014 always check manufacturer guidance<\/li>\n <\/ul>\n

            Frequently Asked Questions<\/strong><\/h2>\n

            How do I choose an antibody for immunohistochemistry?<\/strong><\/h3>\n

            Confirm the antibody has been validated specifically for IHC, not just Western blot or ELISA.<\/p>\n

            Check species reactivity, epitope specificity, and cross-reactivity data. Look for published IHC citations. Then plan your antigen retrieval method and optimize dilution in your specific tissue before committing to a full experiment.<\/p>\n

            What is the difference between monoclonal and polyclonal antibodies in immunohistochemistry?<\/strong><\/h3>\n

            Monoclonals offer higher specificity and lower background but can fail if fixation masks their single target epitope.<\/p>\n

            Polyclonals are more tolerant of fixation because they recognize multiple epitopes, but carry a higher risk of non-specific background. Affinity-purified polyclonals are strongly preferred over crude antiserum for IHC.<\/p>\n

            How do I dilute a primary antibody for IHC?<\/strong><\/h3>\n

            Start with the manufacturer's recommended dilution range as a guide. Run a titration series, at least three concentrations, on positive and negative control tissue.<\/p>\n

            Select the dilution that gives the strongest specific signal with the lowest background. For most rabbit polyclonals, 0.5\u20132 \u00b5g\/mL is a typical starting range; for mouse monoclonals, 1\u20135 \u00b5g\/mL.<\/p>\n

            How long can you leave a primary antibody during IHC incubation?<\/strong><\/h3>\n

            Most IHC protocols use either 1 hour at room temperature or overnight at 4\u00b0C.<\/p>\n

            Overnight incubation at 4\u00b0C often improves signal, especially for low-abundance targets or difficult antigens, without significantly increasing background, provided blocking was done properly.<\/p>\n

            Does immunohistochemistry use secondary antibodies?<\/strong><\/h3>\n

            Yes \u2014 indirect IHC, which is the most common detection approach, uses both a primary and a secondary antibody.<\/p>\n

            The primary antibody binds the target protein. The secondary antibody (conjugated to HRP, AP, or a fluorophore) binds the primary and amplifies the signal for detection.<\/p>\n

            What are the controls required for immunohistochemistry?<\/strong><\/h3>\n

            At minimum, you need a positive control (tissue known to express the target), a negative control (tissue known not to express it), and a no-primary control (full protocol run without primary antibody).<\/p>\n

            An isotype control \u2014 using a non-specific antibody of the same isotype and concentration as the primary \u2014 is also strongly recommended, particularly for regulatory and publication purposes.<\/p>\n

            Can I use two antibodies from the same species in IHC?<\/strong><\/h3>\n

            It is technically possible but requires careful sequential staining protocols and complete inactivation of the first primary-secondary complex before adding the second.<\/p>\n

            What is antibody validation for immunohistochemistry?<\/strong><\/h3>\n

            IHC antibody validation confirms the antibody specifically detects the intended target in tissue, not non-specific proteins.<\/p>\n

            .<\/p>\n

            Final Thoughts<\/strong><\/h2>\n

            Successful IHC comes down to careful antibody selection, proper optimization, and rigorous controls.<\/p>\n

            Choose an antibody validated for IHC, optimize your antigen retrieval and dilution in your specific tissue, and always run the controls that prove your result is real.<\/p>\n

            AbTrivia offers a comprehensive range of IHC-validated antibodies, monoclonal, polyclonal, and recombinant, with complete validation data and technical support to help you get clean results from the start.<\/p>\n","protected":false},"excerpt":{"rendered":"

            Immunohistochemistry is one of the most visually powerful techniques in research and pathology, but it is also one of the most sensitive to antibody choice. The wrong antibody produces high background, non-specific staining, or no signal at all. The right one gives you clean, interpretable results that hold up under scrutiny. This guide covers everything […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-132108","blog","type-blog","status-publish","hentry"],"acf":[],"yoast_head":"\nIHC Antibody Selection and Optimization Guide | AbTrivia<\/title>\n<meta name=\"description\" content=\"Learn how to select, dilute, optimize, and validate antibodies for immunohistochemistry (IHC). Covers monoclonal vs polyclonal, antigen retrieval, a complete practical guide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/\" \/>\n<meta property=\"og:locale\" content=\"ko_KR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IHC Antibody Selection and Optimization Guide | AbTrivia\" \/>\n<meta property=\"og:description\" content=\"Learn how to select, dilute, optimize, and validate antibodies for immunohistochemistry (IHC). Covers monoclonal vs polyclonal, antigen retrieval, a complete practical guide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/\" \/>\n<meta property=\"og:site_name\" content=\"AbTrivia\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-17T02:58:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/\",\"url\":\"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/\",\"name\":\"IHC Antibody Selection and Optimization Guide | AbTrivia\",\"isPartOf\":{\"@id\":\"https:\/\/abtriva.com\/cn\/#website\"},\"datePublished\":\"2026-06-17T02:55:17+00:00\",\"dateModified\":\"2026-06-17T02:58:18+00:00\",\"description\":\"Learn how to select, dilute, optimize, and validate antibodies for immunohistochemistry (IHC). Covers monoclonal vs polyclonal, antigen retrieval, a complete practical guide.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/#breadcrumb\"},\"inLanguage\":\"ko_KR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.abtriva.com\/ko\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blogs\",\"item\":\"https:\/\/www.abtriva.com\/ko\/blog\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunohistochemistry (IHC) Antibody Selection and Optimization Guide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/abtriva.com\/cn\/#website\",\"url\":\"https:\/\/abtriva.com\/cn\/\",\"name\":\"AbTrivia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/abtriva.com\/cn\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ko_KR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IHC Antibody Selection and Optimization Guide | AbTrivia","description":"Learn how to select, dilute, optimize, and validate antibodies for immunohistochemistry (IHC). Covers monoclonal vs polyclonal, antigen retrieval, a complete practical guide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/","og_locale":"ko_KR","og_type":"article","og_title":"IHC Antibody Selection and Optimization Guide | AbTrivia","og_description":"Learn how to select, dilute, optimize, and validate antibodies for immunohistochemistry (IHC). Covers monoclonal vs polyclonal, antigen retrieval, a complete practical guide.","og_url":"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/","og_site_name":"AbTrivia","article_modified_time":"2026-06-17T02:58:18+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/","url":"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/","name":"IHC Antibody Selection and Optimization Guide | AbTrivia","isPartOf":{"@id":"https:\/\/abtriva.com\/cn\/#website"},"datePublished":"2026-06-17T02:55:17+00:00","dateModified":"2026-06-17T02:58:18+00:00","description":"Learn how to select, dilute, optimize, and validate antibodies for immunohistochemistry (IHC). Covers monoclonal vs polyclonal, antigen retrieval, a complete practical guide.","breadcrumb":{"@id":"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/#breadcrumb"},"inLanguage":"ko_KR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.abtriva.com\/ko\/blog\/immunohistochemistry-ihc-antibody-selection-and-optimization-guide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.abtriva.com\/ko\/"},{"@type":"ListItem","position":2,"name":"Blogs","item":"https:\/\/www.abtriva.com\/ko\/blog\/"},{"@type":"ListItem","position":3,"name":"Immunohistochemistry (IHC) Antibody Selection and Optimization Guide"}]},{"@type":"WebSite","@id":"https:\/\/abtriva.com\/cn\/#website","url":"https:\/\/abtriva.com\/cn\/","name":"AbTrivia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/abtriva.com\/cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ko_KR"}]}},"_links":{"self":[{"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/blog\/132108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/blog"}],"about":[{"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/types\/blog"}],"author":[{"embeddable":true,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/comments?post=132108"}],"version-history":[{"count":1,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/blog\/132108\/revisions"}],"predecessor-version":[{"id":132112,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/blog\/132108\/revisions\/132112"}],"wp:attachment":[{"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/media?parent=132108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/categories?post=132108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abtriva.com\/ko\/wp-json\/wp\/v2\/tags?post=132108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}